oral PI3K_-selective kinase inhibitor prodrug
preclinical candidate for breast cancer
from mining of prior PI3K inh., SBDD, and opt.
J. Med. Chem., Dec. 24, 2020
Pfizer, San Diego, CA
PF-06843195
1 min read
Pfizer oral PI3ka-selective kinase inhibitor prodrug
Search By Structure
- OI338
- PF07059013
- AZD0364
- PF-06843195
- TP0586352
- AZD4573
- “compound 42”
- “compound 12”
- BMS-986202
- pamiparib
- linrodostat
- SAR439859
- ACT-1004-1239
- “compound 1”
Molecules of the Month
2023
2022
2021
2020